Development of vaccine approaches to elicit broadly protective influenza-specific immune responses in infants

开发疫苗方法以在婴儿中引发广泛保护性的流感特异性免疫反应

基本信息

项目摘要

Influenza virus infection of neonates can lead to life-threatening disease. The rate of LRTI-associated hospitalizations is >4 times higher in children less than 1 year of age compared to those between 1 and 4 years and infants younger than 6 months of age are particularly vulnerable to the development of severe disease. Current influenza vaccines on the market are not approved for infants <6 months of age as a result of their limited effectiveness in this age group. Overcoming this poor responsiveness will require development of vaccines with greater immunogenicity in this population. Another important area of investigation is the ability of infants to respond to universal vaccines designed to provide protection across multiple strains of influenza. While targeting production of these antibodies by vaccination is highly desirable, our understanding of how effectively newborns can produce them or the accessory signals that can optimally elicit these antibodies is unknown. The ultimate goal of the studies proposed in this application is to identify a vaccine approach for influenza that is safe and broadly protective when delivered to neonates. To evaluate potential strategies, we will use our established African green monkey (AGM) nonhuman primate neonate model. Using this model we previously found that conjugation of the TLR7/8 agonist R848 to inactivated influenza promotes significant increases in virus-specific IgG and IFNγ-producing T cell responses, providing rationale for the continued exploration of this adjuvant in neonates. We will utilize R848 together with heterologous boost or an HA stem construct as approaches to elicit broadly reactive antibody. As part of our analyses we will evaluate the role of Tfh responses in modulating broadly reactive antibody quantity and quality. The results of these studies will provide mechanistic as well as practical information that may lead to the improved design of vaccines that will be efficacious in the vulnerable neonate population.
新生儿流感病毒感染可导致危及生命的疾病。LRTI相关性 1岁以下儿童的住院率是1至4岁儿童的4倍 年龄小于6个月的婴儿特别容易发生严重的 疾病由于以下原因,目前市场上的流感疫苗未被批准用于<6个月的婴儿 他们在这个年龄段的有效性有限。要克服这种反应能力差的问题,就需要开发 免疫原性更强的疫苗。调查的另一个重要领域是 婴儿对通用疫苗作出反应,该疫苗旨在提供对多种流感毒株的保护。 虽然通过疫苗接种靶向产生这些抗体是非常可取的,但我们对如何产生这些抗体的理解是非常重要的。 新生儿可以有效地产生它们,或者可以最佳地引发这些抗体的辅助信号, 未知本申请中提出的研究的最终目标是确定一种疫苗方法, 流感病毒是安全和广泛的保护时,交付给新生儿。为了评估潜在的战略,我们 将使用我们建立的非洲绿色猴(AGM)非人灵长类新生动物模型。利用这个模型,我们 先前发现TLR 7/8激动剂R848与灭活流感病毒的缀合促进了显著的 产生病毒特异性IgG和IFNγ的T细胞应答增加,为持续的 在新生儿中探索这种佐剂。我们将使用R848与异源加强或HA茎 构建体作为引发广泛反应性抗体的方法。作为我们分析的一部分,我们将评估 Tfh在调节广泛反应性抗体数量和质量中的反应。这些研究的结果将 提供机制以及实际的信息,可能会导致改进的疫苗设计, 在脆弱的新生儿群体中有效。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Challenges for the Newborn Following Influenza Virus Infection and Prospects for an Effective Vaccine.
  • DOI:
    10.3389/fimmu.2020.568651
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
    Alexander-Miller MA
  • 通讯作者:
    Alexander-Miller MA
Challenges for the Newborn Immune Response to Respiratory Virus Infection and Vaccination.
  • DOI:
    10.3390/vaccines8040558
  • 发表时间:
    2020-09-24
  • 期刊:
  • 影响因子:
    7.8
  • 作者:
    Crofts KF;Alexander-Miller MA
  • 通讯作者:
    Alexander-Miller MA
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Martha Ann Alexander-Miller其他文献

Martha Ann Alexander-Miller的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Martha Ann Alexander-Miller', 18)}}的其他基金

Development of vaccine approaches to elicit broadly protective influenza-specific immune responses in infants
开发疫苗方法以在婴儿中引发广泛保护性的流感特异性免疫反应
  • 批准号:
    10229523
  • 财政年份:
    2020
  • 资助金额:
    $ 74.88万
  • 项目类别:
Immune regulation by pneumococcus
肺炎球菌的免疫调节
  • 批准号:
    9317155
  • 财政年份:
    2017
  • 资助金额:
    $ 74.88万
  • 项目类别:
Regulation of avidity in T lymphocytes
T 淋巴细胞亲合力的调节
  • 批准号:
    9039367
  • 财政年份:
    2016
  • 资助金额:
    $ 74.88万
  • 项目类别:
Regulation of avidity in T lymphocytes
T 淋巴细胞亲合力的调节
  • 批准号:
    9199573
  • 财政年份:
    2016
  • 资助金额:
    $ 74.88万
  • 项目类别:
Vaccination strategies to overcome immune deficiencies in neonates
克服新生儿免疫缺陷的疫苗接种策略
  • 批准号:
    8840143
  • 财政年份:
    2012
  • 资助金额:
    $ 74.88万
  • 项目类别:
Vaccination strategies to overcome immune deficiencies in neonates
克服新生儿免疫缺陷的疫苗接种策略
  • 批准号:
    8477124
  • 财政年份:
    2012
  • 资助金额:
    $ 74.88万
  • 项目类别:
Vaccination strategies to overcome immune deficiencies in neonates
克服新生儿免疫缺陷的疫苗接种策略
  • 批准号:
    8668895
  • 财政年份:
    2012
  • 资助金额:
    $ 74.88万
  • 项目类别:
Vaccination strategies to overcome immune deficiencies in neonates
克服新生儿免疫缺陷的疫苗接种策略
  • 批准号:
    8319130
  • 财政年份:
    2012
  • 资助金额:
    $ 74.88万
  • 项目类别:
Cellular Immune Responses to Respiratory Infection
对呼吸道感染的细胞免疫反应
  • 批准号:
    7371984
  • 财政年份:
    2004
  • 资助金额:
    $ 74.88万
  • 项目类别:
Cellular Immune Responses to Respiratory Infection
对呼吸道感染的细胞免疫反应
  • 批准号:
    6867421
  • 财政年份:
    2004
  • 资助金额:
    $ 74.88万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 74.88万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 74.88万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 74.88万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 74.88万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 74.88万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 74.88万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 74.88万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 74.88万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 74.88万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 74.88万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了